Mesenchymal Stem Cell Transplantation for COVID-19

Journal Title: Journal of Clinical Immunology & Microbiology - Year 2020, Vol 1, Issue 1

Abstract

In-vitro, Mesenchymal Stem Cell (MSC) populations with potentials of similar multi-lineage differentiation have been obtained from several Bone Marrow (BM) and non-bone marrow tissues, including umbilical cord, placenta, amniotic fluid, adipose tissue, and peripheral blood [1-10]. The clonogenic BM-human MSCs fraction ranges from 10 to 100 Colony-Forming Unit-Fibroblast (CFU-F) per 106 Marrow Mononuclear Cells (MNCs) [11]. BM-human MCSs are characterized by lacking CD11b, CD14, CD19, D34, CD45, CD79α, and Human Leukocyte Antigen (HLA)-DR expression; positive expression of surface antigens CD73, CD90, and CD105; multipotency (i.e., chondrogenic, osteogenic, and adipogenic); and their adherence to plastic [11]. By the year 2000, clinicians increasingly had become interested in intravenously applied MSC therapy [12]. A previous study demonstrated that both human and murine MCSs can induce immune suppression by attracting and killing auto reactive T cells via FasL, therefore stimulating Transforming Growth Factor-beta (TGF-β) production by macrophages and generation of regulatory T cells [13]. The dying T cells that is caused by the interaction involving the MSC-induced Monocyte Chemoattractant Protein-1 (MCP-1) secretion in turn activate macrophages to produce TGF-β, then stimulating regulatory T cells and promoting immune tolerance [14]. The capacity of MSCs for in-vivo differentiation and engraftment and by their efficacy in promoting wound healing highlighted its clinical relevance [15-21].

Authors and Affiliations

Attapon Cheepsattayakorn*, Ruangrong Cheepsattayakorn

Keywords

Related Articles

A Narrative Review on Argentine Hemorrhagic Fever: Junin Virus (JUNV)

Epidemic cases of Argentine hemorrhagic fever (also known as AHF) have been associated with the Junin virus, also known as JUNV, ever since the 1950s. The JUNV arenavirus is endemic to the countries of the New World. In...

COVID-19 Epidemics Monitored Through the Logarithmic Growth Rate and SIR Model

The SIR model is often used to analyse and forecast an epidemic. In this model, the number of patients exponentially increases and decreases in the early and late phases; hence the logarithmic growth rate K is constant a...

Macrophage Responses Against Acellularized Dermal Matrix from Human Versus Porcine Predicts the In-vivo Fibrosis

Background: Due to the possible difference in the manufacturer’s processes, in-vitro and in-vivo tests might be beneficial for the selection of an Acellularized Dermal Matrix (ADM). Methods: ADMs from human and porcin...

Lyme Disease-An Emerging Metazoonosis of Public Health Concern

Recent decades witnessed the emergence of several zoonotic diseases, such as bird flu, Ebola disease, Nipah virus disease, severe acute respiratory syndrome, swine flu, COVID-19 and others [1]. The emergence of these z...

Inundate and Deluge-Hemophagocytic Lymphohistiocytosis

Hemophagocytic lymphohistiocytosis is a pathological syndrome constituted of defective Natural Killer (NK) cell or T cell function engendering unchecked secretions of cytokines and end organ damage on account of accompan...

Download PDF file
  • EP ID EP699074
  • DOI http://dx.doi.org/10.46889/JCIM.2020.1101
  • Views 89
  • Downloads 0

How To Cite

Attapon Cheepsattayakorn*, Ruangrong Cheepsattayakorn (2020). Mesenchymal Stem Cell Transplantation for COVID-19. Journal of Clinical Immunology & Microbiology, 1(1), -. https://europub.co.uk/articles/-A-699074